Series A Preferred Series A Preferred Stock [Member] Award amount Revenue From Grants, Maximum Award Revenue From Grants, Maximum Award Proceeds from issuance of equity securities, net Proceeds from Issuance or Sale of Equity Level 3 Fair Value, Inputs, Level 3 [Member] City Area Code City Area Code Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Consecutive trading days Class of Warrant or Right, Threshold Consecutive Trading Days Class of Warrant or Right, Threshold Consecutive Trading Days Subsequent Events Subsequent Events, Policy [Policy Text Block] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Title of 12(b) Security Title of 12(b) Security Exercisable, weighted-average exercise price (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Related Party [Axis] Related Party [Axis] Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Accrued issuance costs for public offering Stock Issuance Costs Accrued and Amortized Stock Issuance Costs Accrued and Amortized Schedule of Variables used in Black-Scholes Model Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Note payable Notes Payable, Current Warrant liability Derivative Liability, Current Application of New Accounting Standards and Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Assets Assets [Abstract] Equity, beginning balance (shares) Equity, ending balance (shares) Shares, Outstanding Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Entity Ex Transition Period Entity Ex Transition Period Entity Address, Postal Zip Code Entity Address, Postal Zip Code Conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Net loss per share (in dollars per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Fair value of Flex Pharma outstanding options on the merger date Business Combination, Consideration Transferred, Fair Value of Outstanding Options Business Combination, Consideration Transferred, Fair Value of Outstanding Options Number of shares outstanding Outstanding, Beginning Balance (shares) Outstanding, Ending Balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Prepaid insurance Prepaid Insurance Issuance of equity securities Shares issued, value Stock Issued During Period, Value, New Issues Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Total operating expenses Operating Expenses Property and equipment, net Property, Plant and Equipment, Net Due to related party Due to Related Parties Discount rate Measurement Input, Discount Rate [Member] Total assets Assets Entity Shell Company Entity Shell Company Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Cover [Abstract] Exercisable, weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Document Type Document Type Subsequent Event Subsequent Event [Member] Non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Net loss per share (usd per share) Earnings Per Share, Basic and Diluted Issuance of equity securities for license (shares) Stock Issued During Period, Shares, Issued for Services Expected life (years) Warrants and Rights Outstanding, Term Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Current funding available Revenue From Grants, Aggregate Amount Received, Current Funding Available Revenue From Grants, Aggregate Amount Received, Current Funding Available Award term Revenue From Grants, Award Term Revenue From Grants, Award Term Current liabilities: Liabilities, Current [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Statistical Measurement [Axis] Statistical Measurement [Axis] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Cash payment to related party Repayments of Related Party Debt Total fair value of liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Outstanding, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Preferred Stock Preferred Stock [Member] Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Equity [Abstract] Equity [Abstract] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Total fair value of assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Wedbush Wedbush Securities Inc. [Member] Wedbush Securities Inc. Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Schedule of Unaudited Pro Forma Results Business Acquisition, Pro Forma Information [Table Text Block] Accounts payable Increase (Decrease) in Accounts Payable Document Quarterly Report Document Quarterly Report Commitments and Contingencies Commitments and Contingencies Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Short-term Debt [Line Items] Short-term Debt [Line Items] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Class of Stock [Domain] Class of Stock [Domain] Weighted-average number of common shares outstanding — basic and diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Exercisable (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Net loss Business Acquisition, Pro Forma Net Income (Loss) Common stock, shares authorized Common Stock, Shares Authorized Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Price per share (usd per share) Sale of Stock, Price Per Share Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Entity Emerging Growth Company Entity Emerging Growth Company Sale of Stock [Domain] Sale of Stock [Domain] Equity-based compensation expense Share-based Payment Arrangement, Noncash Expense Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Document Fiscal Period Focus Document Fiscal Period Focus Offering costs Payments of Stock Issuance Costs Income Taxes Income Tax, Policy [Policy Text Block] Equity-based compensation expense Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Balance at December 31, 2019 Balance at March 31, 2020 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Schedule of Fair Value Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Goodwill and intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Goodwill and Intangible Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Goodwill and Intangible Assets Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Schedule of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Loss before other income (expense) Operating Income (Loss) Goodwill Goodwill Preferred stock, shares issued Preferred Stock, Shares Issued Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Statement [Line Items] Statement [Line Items] Measurement Input Type [Axis] Measurement Input Type [Axis] Grant revenue Revenue from Contract with Customer, Excluding Assessed Tax Liabilities and stockholders' equity (deficit) Liabilities and Equity [Abstract] Equity-based compensation expense (shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Other assets Other Assets, Noncurrent Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Weighted-average exercise price, Beginning Balance (in usd per share) Weighted-average exercise price, Ending Balance (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Loss Per Share Earnings Per Share, Policy [Policy Text Block] Plan Name [Axis] Plan Name [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Over-Allotment Option Over-Allotment Option [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Amendment Flag Amendment Flag Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Weighted-Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Common stock, shares outstanding Common Stock, Shares, Outstanding Current funding received Revenue From Grants, Current Funding Received Revenue From Grants, Funding Received During Period Unrecognized compensation cost, options Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Class of Stock [Axis] Class of Stock [Axis] Flex Pharma market capitalization at closing Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Plan Name [Domain] Plan Name [Domain] STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Sale of Stock [Axis] Sale of Stock [Axis] Use of Estimates Use of Estimates, Policy [Policy Text Block] ORGANIZATION AND OPERATIONS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Fair value of rights to warrants Business Combination, Consideration Transferred, Fair Value of Rights to Warrants Business Combination, Consideration Transferred, Fair Value of Rights to Warrants Number of rights per share Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Subsequent Event [Table] Subsequent Event [Table] Note Payable Notes Payable to Banks [Member] Unrecognized compensation cost, recognition period Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Accounting Policies [Abstract] Accounting Policies [Abstract] Additional Paid-In Capital Additional Paid-in Capital [Member] Local Phone Number Local Phone Number Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Issuance of equity securities for license Stock Issued During Period, Value, Issued for Services Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities 2015 Plan Equity Incentive Plan 2015 [Member] Equity Incentive Plan 2015 [Member] Equity-Based Compensation Share-based Payment Arrangement [Policy Text Block] Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Impairment charges of long-lived assets Impairment of Long-Lived Assets Held-for-use Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Additional paid-in capital Additional Paid in Capital Interest rate Debt Instrument, Interest Rate, Stated Percentage Change in fair value of warrant liability Change in fair value of warrant liability Change in Fair Value Fair Value Adjustment of Warrants Forfeited, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Entity Address, Address Line One Entity Address, Address Line One Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Entity Address, Address Line Two Entity Address, Address Line Two Business Combinations [Abstract] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Number of stock options granted (shares) Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Payments on note payable Repayments of Notes Payable Entity Address, State or Province Entity Address, State or Province Warrants Derivatives, Policy [Policy Text Block] Satisfy success fee Satisfy Success Fee Due to Related Party [Member] Satisfy Success Fee Due to Related Party Business Acquisition [Axis] Business Acquisition [Axis] Total current assets Assets, Current Entity Current Reporting Status Entity Current Reporting Status Stock options, contractual term Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Expected volatility Measurement Input, Price Volatility [Member] Net loss Net loss Net Income (Loss) Attributable to Parent Loan Payable Loans Payable [Member] Common Stock Common Stock [Member] Current assets: Assets, Current [Abstract] Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Total purchase consideration Business Combination, Consideration Transferred Grants receivable Increase (Decrease) in Receivables Business Acquisition [Line Items] Business Acquisition [Line Items] Interest income net Interest Income (Expense), Nonoperating, Net General and administrative General and Administrative Expense Accounts payable Accounts Payable, Current Grants receivable from CPRIT Receivables, Net, Current Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Prepaid expense and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Extension term Revenue From Grants, Extension Term Revenue From Grants, Extension Term Voting interest acquired Business Acquisition, Percentage of Voting Interests Acquired Entity Small Business Entity Small Business Commitments and Contingencies Disclosure [Abstract] Entity Interactive Data Current Entity Interactive Data Current Common stock, shares issued Common Stock, Shares, Issued Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Due to/from related party Increase (Decrease) in Due to Related Parties Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Period the right is unexercisable Class of Warrant or Right, Period Warrants or Rights Unexercisable Class of Warrant or Right, Period Warrants or Rights Unexercisable Entity Filer Category Entity Filer Category Profit Interest Units Profit Interest Units [Member] Profit Interest Units Related Party Transaction [Domain] Related Party Transaction [Domain] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Total liabilities and stockholders' equity Liabilities and Equity Preferred shares converted to common shares (shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Entity Address, City or Town Entity Address, City or Town Summary of Changes in Fair Value of Level 3 Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Measurement Frequency [Axis] Measurement Frequency [Axis] Warrants measurement input Warrants Outstanding, Measurement Input Warrants Outstanding, Measurement Input Flex Pharma Flex Pharma [Member] Flex Pharma Shares remaining available for grant of stock awards (shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Award Type [Domain] Award Type [Domain] Operating expenses: Operating Expenses [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Preferred stock, shares authorized Preferred Stock, Shares Authorized Granted, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Issuance of equity securities (shares) Shares issued Stock Issued During Period, Shares, New Issues Principles of Consolidation Consolidation, Policy [Policy Text Block] Stockholders' equity (deficit): Stockholders' Equity Attributable to Parent [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Number of shares issued Sale of Stock, Number of Shares Issued in Transaction Ownership [Domain] Ownership [Domain] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Financial Instruments and Credit Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Number of shares called by warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Recurring Fair Value, Recurring [Member] Total liabilities Liabilities REVERSE ACQUISITION AND DISPOSAL Business Combination Disclosure [Text Block] Award Type [Axis] Award Type [Axis] PREPAID EXPENSES AND OTHER CURRENT ASSETS Other Current Assets [Text Block] Common stock, $0.0001 par value; 100,000,000 shares authorized; 13,650,838 and 4,519,533 shares issued at March 31, 2020 and December 31, 2019, and 13,645,677 and 4,511,174 shares outstanding at March 31, 2020 and December 31, 2019, respectively Common Stock, Value, Issued Expected dividend Measurement Input, Expected Dividend Rate [Member] Research and development Research and Development Expense Class of Stock [Line Items] Class of Stock [Line Items] Subsequent Events [Abstract] Subsequent Events [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accumulated Deficit Retained Earnings [Member] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Matching funds requirement Revenue From Grants, Matching Funds Requirement Revenue From Grants, Matching Funds Requirement Subsequent Event [Line Items] Subsequent Event [Line Items] Prepaid clinical trial expenses Prepaid Clinical Trial Expense Prepaid Clinical Trial Expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Equity Components [Axis] Equity Components [Axis] Document Period End Date Document Period End Date Other prepaid and current assets Other Assets, Current Statement [Table] Statement [Table] Entity Registrant Name Entity Registrant Name Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Total stockholders' equity Equity, beginning balance Equity, ending balance Stockholders' Equity Attributable to Parent Grant contract amount Contract with Customer, Liability Fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Deferred revenue Contract with Customer, Liability, Current Conversion of liabilities to equity Debt Conversion, Converted Instrument, Amount Maximum Maximum [Member] Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities Accrued Expenses And Other Current Liabilities GRANTS RECEIVABLE Loans, Notes, Trade and Other Receivables Disclosure [Text Block] FAIR VALUE OF FINANCIAL INSTRUMENTS Fair Value Disclosures [Text Block] Measurement Input Type [Domain] Measurement Input Type [Domain] Receivables [Abstract] Class B Common Class B [Member] Related Party [Domain] Related Party [Domain] Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Outstanding, weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Warrant value Warrants and Rights Outstanding Ownership [Axis] Ownership [Axis] Depreciation, amortization and impairment Depreciation, Depletion and Amortization Preferred shares converted to common shares Stock Issued During Period, Value, Conversion of Convertible Securities Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Ownership percentage by noncontrolling Owner Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Issuance of shares for license Stock Issued Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Accumulated deficit Retained Earnings (Accumulated Deficit) Preferred stock, $0.0001 par value; 10,000,000 shares authorized; 468,694 issued and outstanding Preferred Stock, Value, Issued Common Units Common Units [Member] Common Units Security Exchange Name Security Exchange Name Summary of Purchase Consideration Schedule of Business Acquisitions, by Acquisition [Table Text Block] Entity Tax Identification Number Entity Tax Identification Number Antidilutive securities excluded from computation of earnings per share (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Grants Receivable and Revenue Recognition Revenue [Policy Text Block] Principal amount Debt Instrument, Face Amount Related Party Transaction [Axis] Related Party Transaction [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Equity Component [Domain] Equity Component [Domain] Trading Symbol Trading Symbol Expected life (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Minimum Minimum [Member] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Document Transition Report Document Transition Report University of Utah Research Foundation University of Utah Research Foundation [Member] University of Utah Research Foundation Employee stock option Share-based Payment Arrangement, Option [Member] Accounts payable, accrued liabilities and other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Class A Common Class A [Member] Aggregate amount received Revenue From Grants, Aggregate Amount Received Revenue From Grants, Aggregate Amount Received Legal Entity [Axis] Legal Entity [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Summary of Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Revenues Business Acquisition, Pro Forma Revenue Income Statement [Abstract] Income Statement [Abstract] Exercisable, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Entity [Domain] Entity [Domain] EQUITY-BASED COMPENSATION Share-based Payment Arrangement [Text Block] Continued payments, percent of net sales Revenue From Grants, Revenue-sharing Payments, Continued Payments, Percent of Net Sales Revenue From Grants, Revenue-sharing Payments, Continued Payments, Percent of Net Sales